Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells
Sign Up to like & getrecommendations! Published in 2022 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2021-004268
Abstract: Background Dendritic cells (DCs) are professional antigen presenting cells that initiate immune defense to pathogens and tumor cells. Human tumors contain only few DCs that mostly display a non-activated phenotype. Hence, activation of tumor-associated DCs… read more here.
Keywords: human tumor; tl8 506; cdcs; blood ... See more keywords